MGAM (maltase-glucoamylase) encodes an alpha-(1,4) exo-glucosidase essential for dietary starch digestion in the small intestine. The enzyme cleaves non-reducing alpha-(1,4)-linked glucose residues in linear dextrins while retaining anomeric center stereochemistry, primarily hydrolyzing short oligomaltoses containing two to seven glucose residues 1. MGAM can also cleave alpha-(1,2), alpha-(1,3) and alpha-(1,6) glycosidic linkages with lower efficiency 1. The enzyme accounts for approximately 20% of mucosal maltase activity, with sucrase-isomaltase contributing the remaining 80% 2. MGAM functions alongside other intestinal glucosidases to complete the final steps of starch digestion, making it an important therapeutic target for type-2 diabetes treatment 1. Clinical significance includes impaired starch digestion in congenital sucrase-isomaltase deficiency patients, which can be documented using carbon-13 breath tests 2. Population genetics studies suggest MGAM has undergone adaptive evolution in Peruvian populations with a ~9,547-year-old haplotype likely selected for efficient potato starch digestion 3. Additionally, MGAM overexpression has been identified in oral squamous cell carcinomas, suggesting potential roles beyond carbohydrate metabolism 4.